Suggest your country as a destination for the IMS Annual Meeting in 2026 or 2027
The IMS is currently soliciting suggestions from members for the locations of the Annual Meetings in 2026 (in Europe) and 2027 (outside of Europe and North America). We are soliciting suggestions for potential sites. If you feel the city or country that you represent is appropriate for the IMS Annual Meeting, please share pertinent details about the location and a very brief description about why it would be an attractive site, including capacity of the convention facility and travel logistics. Although the meetings are managed by IMS, the local host will be considered for inclusion in the organizing committee.
- Suggestions are due no later than December 1, 2022.
- Countries nominated by the general membership will be included in the venue search process that will take place in January 2023.
- IMS will do the logistical analysis and will consider counties that have adequate convention facilities and direct airlinks.
To learn more about past IMS Annual Meetings, please visit our past events page.
If you wish to recommend your country as a potential destination for the meeting, please complete this form:
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
